| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_073119acbd235b93306fa836bdf25b6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 |
| filingDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be74b013224d99da62e9aa953cd488e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_994876db35ba8a54b7e7aa3762bacdb2 |
| publicationDate |
2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006127639-A2 |
| titleOfInvention |
Process for preparation of isotonic aqueous injection of ropivacaine |
| abstract |
The preparation of an injectable solution of ropivacaine by dissolving ropivacaine base in aqueous acidic solution having a molar ratio of acid to ropivacaine base greater than 1:1 eliminates the need for a hydrochloride or hydrochloride monohydrate intermediate in the manufacture of the injectable. The osmolality can be adjusted as needed. The excess acid is neutralized with a base. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1891010-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106177970-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106177970-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3331516-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102697708-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105816432-A |
| priorityDate |
2005-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |